IRCT20090905002417N21已完成2 期
The effect of Rosuvastatin on the incidence of contrast nephropathy in patients with chronic renal failure receiving contrast
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 90 years（—）
- 性别
- All
入选标准
- •absence of Statin use during past 3 months
- •eGFR between 30 - 60 cc/min/1.73m2
- •not pregnant
- •absence use of contrast during past 10 days
- •absence use of Metformin
排除标准
- •Acute coronary syndrome
- •history of allergy to contrast media
- •death during 72 hours after receiving contrast media
- •end stage renal disease
研究者
相似试验
已完成
3 期
The assessment of effect of Rosuvastatin use in venous thromboembolismVenous thromboembolism includes deep vein thrombosis and pulmonary embolism.venous embolism and thrombosisCode I82IRCT20210416050990N1Shahid Beheshti University of Medical Sciences220
已完成
3 期
Evaluation of the effects of Rosuvastatin in the treatment of patients with deep vein thrombosis(DVT)IRCT20150621022852N4Shahid Beheshti University of Medical Sciences50
招募中
不适用
Comparison between the effect of Rosuvastatin and Orlept (Sodium Valproate) in Decrease of migraine headachesMigraine headaches.MigraineIRCT20180114038369N1Ghoum University of Medical Sciences40
已完成
不适用
Pleiotropic effects of rosuvastatin in patients with coronary artery disease. A randomized, parallel, open-label study, rosuvastatin 10mg vs ezetimibe 10mg/rosuvastatin 2.5mg.Coronary artery diseaseJPRN-UMIN000003746Department of Cardiovascular Medicine, Akita University Graduate School of Medicine40
招募中
不适用
Evaluation of the effect of rosuvastatin on renoprotective effectType 2 diabetesJPRN-UMIN000021583Rosuvastatin-kidney study group40